Ottawa, Canada

Chantal Lemay

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Turnstone Limited Partnership. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chantal Lemay. Retrieved from https://idiyas.com/inventor/chantal-lemay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chantal Lemay: Innovator in Vaccination Methods

Introduction

Chantal Lemay is a prominent inventor based in Ottawa, Canada. She has made significant contributions to the field of vaccination through her innovative methods. Her work focuses on enhancing vaccine efficacy by incorporating histone deacetylase inhibitors.

Latest Patents

Chantal Lemay holds a patent for a method of vaccination that comprises a histone deacetylase inhibitor. This method involves administering a histone deacetylase inhibitor alongside a vaccine that expresses an antigen to which the mammal has pre-existing immunity. This innovative approach aims to improve the immune response in mammals.

Career Highlights

Chantal Lemay is associated with Turnstone Limited Partnership, where she continues to develop her groundbreaking ideas. Her dedication to advancing vaccination methods has positioned her as a key figure in the field.

Collaborations

Chantal has collaborated with notable colleagues, including Byram Bridle and Brian D Lichty. These partnerships have fostered a collaborative environment that enhances research and innovation in vaccination.

Conclusion

Chantal Lemay's contributions to vaccination methods highlight her role as an influential inventor in the field. Her innovative approach promises to improve vaccine efficacy and has the potential to impact public health positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…